Accessibility Menu
Pfizer logo

Pfizer(NYSE) PFE

Market Cap$159.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1968)+38,599%
5 Year-25%
1 Year+17%
1 Month+15%
Premium Feature
Moneyball Superscore
57/100
$28.01
+0.77%
+0.22Today
After hours$28.06+$0.05 (+0.20%)
Pfizer last closing stock price
MetricPriceDate
Last closeUSD 28.072026-08-21
Pfizer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.78%USD 26.792026-08-14
1 month+15.07%USD 24.392026-07-22
3 month+10.27%USD 25.452026-05-22
Year to date+18.55%USD 23.682025-12-31
1 year+16.7%USD 24.052025-08-21
3 year-7.59%USD 30.382023-08-22
5 year-24.93%USD 37.392021-08-20
Since inception+38,599.19%USD 0.071968-01-02

Pfizer Financials at a Glance

Market Cap

$159.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$63.70B

Net Income (TTM)

$4.34B

EPS (TTM)

$0.76

P/E Ratio

37.17

Dividend

$1.72

Beta (Volatility)

0.40 (Low)

Price

$28.01

Volume

37,109,565.048

Open

$27.77

Previous Close

$28.07

Daily Range

$27.66 - $28.43

52-Week Range

$23.58 - $28.75

Estimated Earnings Date

Nov 3, 2026

PFE News

23_11_20 A medical professional filling a needle from a bottle of medicine _MF Dload vaccine needle injection doctor-1200x801-d21b45d

Prediction: This Is Where Pfizer Stock Will Be in 2030

Reuben Gregg BrewerAug 22, 2026
male investor at home remote metics business data analytics

Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the Market

James BrumleyAug 18, 2026
Two scientists looking at a monitor showing brain scans.

4 Best Cancer Stocks for 2026 and How to Invest

Keith SpeightsAug 16, 2026
Pills-in-a-dollar-sign.jpg

4 Best Pharmaceutical Stocks for 2026 and How to Invest

Keith SpeightsAug 14, 2026
Woman using gloves to hold up and inspect a red pill.

Biotech vs. Pharma: What's the Difference?

Keith SpeightsAug 12, 2026
Pfizer logo

Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock

Prosper Junior BakinyAug 11, 2026
Concerned investor looking at a stock chart on a computer.

Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?

David Jagielski, CPAAug 10, 2026
Happy person fist holding a calculator reading "dividends"

20 Best High-Yield Dividend Stocks for 2026 and How to Invest

Matt DiLalloAug 7, 2026
Page 1

PFE: Motley Fool Moneyball Superscore

57

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pfizer

Pfizer Inc. makes medicines and vaccines to treat people. Its products help doctors fight infections and chronic diseases. The company sells these treatments to hospitals and pharmacies worldwide.

Pills, Vaccines, and Global Care

  • Biopharma: Medicines and vaccines for cardiovascular health, oncology, and rare medical conditions.
  • Specialized Treatments: Oral medications and vaccines used to prevent and treat COVID-19.
  • Pfizer CentreOne: Manufacturing services and pharmaceutical ingredients provided to other biopharmaceutical businesses.

Building for Future Growth

  • Acquired Metsera in Nov. 2025 to expand research into new obesity treatments.
  • Entered a strategic collaboration with Innovent in May 2026 to develop cancer medicines.
  • Announced a multiyear program in 2026 to optimize its global manufacturing network.

Why Pfizer Stands Out

Pfizer maintains a diverse portfolio of advanced biologics, small molecule drugs, and immunotherapies for various health conditions. Its global distribution network reaches a wide customer base including wholesalers, government agencies, and medical practices.

A Look at the Ledger

  • Total revenues were $15.0 billion in the second quarter of 2026, up 3% year over year.
  • Net loss attributable to Pfizer common shareholders was $248 million in the quarter ended June 28, 2026.
  • Adjusted diluted EPS was $0.77 in the three-month period ended June 28, 2026.
  • Cash provided by operating activities was $3,450 million in the six-month period ended June 28, 2026.

Bottom Line

Pfizer has shifted its primary focus toward oncology and specialized treatments while implementing programs to improve manufacturing efficiency. This transition helps the company manage patent expirations and navigate changing global health needs.

AI Generated • Aug 4, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

75,000

CEO

Albert Bourla, PhD, DVM

Website

www.pfizer.com

Headquarters

New York City, NY 10001-2192, US

PFE Financials

Key Financial Metrics (TTM)

Gross Margin

71.32%

Operating Margin

25.08%

Net Income Margin

6.81%

Return on Equity

4.89%

Return on Capital

10.03%

Return on Assets

2.16%

Earnings Yield

2.69%

Dividend Yield

6.13%

Payout Ratio

2.26%

Stock Overview

Market Cap

$159.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.70B

Volume

37.11M

Avg. Volume

42.30M

Financials (TTM)

Gross Profit

$45.43B

Operating Income

$15.98B

EBITDA

$12.62B

Operating Cash Flow

$13.40B

Capital Expenditure

-$2.42B

Free Cash Flow

$10.99B

Cash & ST Invst.

$11.70B

Total Debt

$63.19B

Pfizer Performance Analysis

Pfizer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 100,330,000,00023.4%
20232023-12-31USD 59,553,000,000-40.6%
20242024-12-31USD 63,627,000,0006.8%
20252025-12-31USD 62,579,000,000-1.6%
Pfizer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2813.7%
Q42025-12-315.4%
Q12026-03-29-17.7%
Q22026-06-284.0%
Pfizer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 5.4741.0%
20232023-12-31USD 0.37-93.2%
20242024-12-31USD 1.41276.4%
20252025-12-31USD 1.36-3.6%
Pfizer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2821.6%
Q42025-12-31-146.8%
Q12026-03-29262.1%
Q22026-06-28-109.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$15.03B

+2.6%

Gross Profit

$10.94B

+16.2%

Gross Margin

72.78%

N/A

Market Cap

$159.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.13M

N/A

Employees

75,000

N/A

Net Income

-$246.00M

-108.5%

EBITDA

$1.20B

-77.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$11.70B

-11.7%

Total Debt

$63.19B

+2.3%

Accounts Receivable

$12.49B

-22.4%

Inventory

$9.95B

-14.8%

Long Term Debt

$60.50B

+5.2%

Short Term Debt

$2.70B

-37.2%

Return on Assets

2.16%

N/A

Return on Invested Capital

9.48%

N/A

Free Cash Flow

$302.00M

+125.2%

Operating Cash Flow

$835.00M

+243.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DHRDanaher Corporation
$218.85+1.36%
GILDGilead Sciences, Inc.
$146.12+1.87%
BMYBristol-Myers Squibb Company
$67.01+2.35%
SYKStryker Corporation
$329.45+0.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About PFE

What is the current price of Pfizer?

Pfizer is trading at $28.07 per share.

What is the 52-week range for Pfizer?

Over the past 52 weeks, Pfizer has traded between $23.58 and $28.75.

How much debt does Pfizer have?

As of the most recent reporting period, Pfizer reported total debt of $63.19B.

How much cash does Pfizer have on hand?

Pfizer reported $976.00M in cash and cash equivalents in its most recent financial results.

What is Pfizer’s dividend yield?

Pfizer currently has a dividend yield of 6.13%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services